Related Experiment Video
Updated: Sep 20, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Adjusting the scope of natural killer cells in cancer therapy
Zihen Shen1, Xiangpeng Meng1, Jai Rautela2
1Biomedicine Discovery Institute and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Abstract:
Natural killer (NK) cells have evolved to detect abnormalities in tissues arising from infection with pathogens, genomic damage, or transformation and respond rapidly to the production of potent proinflammatory and cytolytic mediators. While this acute proinflammatory response is highly efficient at orchestrating sterilizing immunity to pathogens in a matter of days, cellular transformation often avoids the innate detection mechanisms of NK cells. When cellular transformation results in malignancy, tumor cells and/or the tumor microenvironment can evolve additional mechanisms to circumvent NK cell responses, and cancer is now a dominant disease burden worldwide. Here, we review recent advances in our understanding of the combined relationship between malignancies and natural killer (NK) cells, learn from recent clinical efforts in therapeutically targeting natural killer (NK) cells in cancer and outline some emerging therapeutic concepts that aim to improve the innate immune response against cancer.
Insights
Natural killer (NK) cells fight infections but can be evaded by cancer cells. This review explores NK cell-cancer interactions and therapeutic strategies to enhance innate immunity against malignancies.
Area of Science:
- Immunology
- Oncology
Background:
- Natural killer (NK) cells are crucial for detecting and eliminating abnormal cells, including those infected by pathogens or undergoing transformation.
- Despite their role in innate immunity, cancer cells and their microenvironment often develop mechanisms to evade NK cell surveillance.
- Cancer represents a significant global health burden, underscoring the need for effective immune-based therapies.
Purpose of the Study:
- To review recent advancements in understanding the interplay between malignancies and NK cells.
- To analyze current clinical efforts targeting NK cells for cancer therapy.
- To outline novel therapeutic concepts for bolstering the innate immune response against cancer.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of clinical trial data and therapeutic strategies.
- Synthesis of emerging concepts in cancer immunotherapy.
Main Results:
- NK cells are essential in early defense but are frequently subverted by advanced cancers.
- Therapeutic targeting of NK cells shows promise but faces challenges in overcoming tumor evasion tactics.
- Understanding NK cell biology offers new avenues for cancer treatment development.
Conclusions:
- NK cell-mediated immunity is a critical component of cancer immunosurveillance.
- Overcoming NK cell evasion by tumors is key to successful cancer immunotherapy.
- Future strategies should focus on enhancing NK cell activity and overcoming tumor resistance for improved cancer treatment outcomes.
More Related Videos
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Tumor Immunotherapy
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Targeted Cancer Therapies
There are several types of targeted therapies against...

